Registro:

Referencias:

• Lydon, J.P., Sivaraman, L., Conneely, O.M., A reappraisal of progesterone action in the mammary gland (2000) J Mammary Gland Biol Neoplasia, 5, pp. 325-338
• Ismail, P.M., Amato, P., Soyal, S.M., DeMayo, F.J., Conneely, O.M., O'Malley, B.W., Lydon, J.P., Progesterone involvement in breast development and tumorigenesis - as revealed by progesterone receptor "knockout" and "knockin" mouse models (2003) Steroids, 68, pp. 779-787
• Boonyaratanakornkit, V., Scott, M.P., Ribon, V., Sherman, L., Anderson, S.M., Maller, J.L., Miller, W.T., Edwards, D.P., Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases (2001) Mol Cell, 8, pp. 269-280
• Braunsberg, H., Coldham, N.G., Leake, R.E., Cowan, S.K., Wong, W., Actions of a progestogen on human breast cancer cells: Mechanisms of growth stimulation and inhibition (1987) Eur J Cancer Clin Oncol, 23, pp. 563-571
• Clarke, C.L., Sutherland, R.L., Progestin regulation of cellular proliferation (1990) Endocr Rev, 11, pp. 266-301
• Groshong, S.D., Owen, G.I., Grimison, B., Schauer, I.E., Todd, M.C., Langan, T.A., Sclafani, R.A., Horwitz, K.B., Biphasic regulation of breast cancer cell growth by progesterone: Role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1) (1997) Mol Endocrinol, 11, pp. 1593-1607
• Kiss, R., Paridaens, R.J., Heuson, J.C., Danguy, A.J., Effect of progesterone on cell proliferation in the MXT mouse hormone-sensitive mammary neoplasm (1986) J Natl Cancer Inst, 77, pp. 173-178
• Lange, C.A., Richer, J.K., Shen, T., Horwitz, K.B., Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways (1998) J Biol Chem, 273, pp. 31308-31316
• Manni, A., Badger, B., Wright, C., Ahmed, S.R., Demers, L.M., Effects of progestins on growth of experimental breast cancer in culture: Interaction with estradiol and prolactin and involvement of the polyamine pathway (1987) Cancer Res, 47, pp. 3066-3071
• Shen, T., Horwitz, K.B., Lange, C.A., Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294 (2001) Mol Cell Biol, 21, pp. 6122-6131
• Moore, M.R., Conover, J.L., Franks, K.M., Progestin effects on long-term growth, death, and Bcl-xL in breast cancer cells (2000) Biochem Biophys Res Commun, 277, pp. 650-654
• Moore, M.R., A rationale for inhibiting progesterone-related pathways to combat breast cancer (2004) Curr Cancer Drug Targets, 4, pp. 183-189
• Castoria, G., Barone, M.V., Di Domenico, M., Bilancio, A., Ametrano, D., Migliaccio, A., Auricchio, F., Non-transcriptional action of oestradiol and progestin triggers DNA synthesis (1999) EMBO J, 18, pp. 2500-2510
• Migliaccio, A., Piccolo, D., Castoria, G., Di Domenico, M., Bilancio, A., Lombardi, M., Gong, W., Auricchio, F., Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor (1998) EMBO J, 17, pp. 2008-2018
• Lange, C.A., Richer, J.K., Horwitz, K.B., Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals (1999) Mol Endocrinol, 13, pp. 829-836
• Richer, J.K., Lange, C.A., Manning, N.G., Owen, G., Powell, R., Horwitz, K.B., Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity (1998) J Biol Chem, 273, pp. 31317-31326
• Labriola, L., Salatino, M., Proietti, C.J., Pecci, A., Coso, O.A., Kornblihtt, A.R., Charreau, E.H., Elizalde, P.V., Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells (2003) Mol Cell Biol, 23, pp. 1095-1111
• Proietti, C., Salatino, M., Rosemblit, C., Carnevale, R., Pecci, A., Kornblihtt, A.R., Molinolo, A.A., Elizalde, P.V., Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells (2005) Mol Cell Biol, 25, pp. 4826-4840
• Balana, M.E., Lupu, R., Labriola, L., Charreau, E.H., Elizalde, P.V., Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas (1999) Oncogene, 18, pp. 6370-6379
• Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Ockene, J., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial (2002) JAMA, 288, pp. 321-333
• Chlebowski, R.T., Hendrix, S.L., Langer, R.D., Stefanick, M.L., Gass, M., Lane, D., Rodabough, R.J., McTiernan, A., Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative Randomized Trial (2003) JAMA, 289, pp. 3243-3253
• Tsai, M.J., O'Malley, B.W., Molecular mechanisms of action of steroid/thyroid receptor superfamily members (1994) Annu Rev Biochem, 63, pp. 451-486
• Edwards, D.P., Wardell, S.E., Boonyaratanakornkit, V., Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways (2002) J Steroid Biochem Mol Biol, 83, pp. 173-186
• Ballare, C., Uhrig, M., Bechtold, T., Sancho, E., Di Domenico, M., Migliaccio, A., Auricchio, F., Beato, M., Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells (2003) Mol Cell Biol, 23, pp. 1994-2008
• Hiscox, S., Morgan, L., Green, T.P., Barrow, D., Gee, J., Nicholson, R.I., Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells (2006) Breast Cancer Res Treat, 97, pp. 263-274
• Summy, J.M., Gallick, G.E., Src family kinases in tumor progression and metastasis (2003) Cancer Metastasis Rev, 22, pp. 337-358
• Shupnik, M.A., Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: Implications for cell proliferation (2004) Oncogene, 23, pp. 7979-7989
• Gonzalez, L., Agullo-Ortuno, M.T., Garcia-Martinez, J.M., Calcabrini, A., Gamallo, C., Palacios, J., Aranda, A., Martin-Perez, J., Role of c-Src in human MCF7 breast cancer cell tumorigenesis (2006) J Biol Chem, 281, pp. 20851-20864
• Ishizawar, R.C., Tice, D.A., Karaoli, T., Parsons, S.J., The C terminus of c-Src inhibits breast tumor cell growth by a kinase-independent mechanism (2004) J Biol Chem, 279, pp. 23773-23781
• Myoui, A., Nishimura, R., Williams, P.J., Hiraga, T., Tamura, D., Michigami, T., Mundy, G.R., Yoneda, T., C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis (2003) Cancer Res, 63, pp. 5028-5033
• Tan, M., Li, P., Klos, K.S., Lu, J., Lan, K.H., Nagata, Y., Fang, D., Yu, D., ErbB2 promotes Src synthesis and stability: Novel mechanisms of Src activation that confer breast cancer metastasis (2005) Cancer Res, 65, pp. 1858-1867
• Rucci, N., Recchia, I., Angelucci, A., Alamanou, M., Del Fattore, A., Fortunati, D., Susa, M., Teti, A., Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy (2006) J Pharmacol Exp Ther, 318, pp. 161-172
• Costa, S.D., Lange, S., Klinga, K., Merkle, E., Kaufmann, M., Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer-results of the analysis of 670 patients with 11 years of follow-up (2002) Eur J Cancer, 38, pp. 1329-1334
• Bardou, V.J., Arpino, G., Elledge, R.M., Osborne, C.K., Clark, G.M., Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases (2003) J Clin Oncol, 21, pp. 1973-1979
• Balana, M.E., Labriola, L., Salatino, M., Movsichoff, F., Peters, G., Charreau, E.H., Elizalde, P.V., Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells (2001) Oncogene, 20, pp. 34-47
• Salatino, M., Schillaci, R., Proietti, C.J., Carnevale, R., Frahm, I., Molinolo, A.A., Iribarren, A., Elizalde, P.V., Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity (2004) Oncogene, 23, pp. 5161-5174
• Puricelli, L., Proiettii, C.J., Labriola, L., Salatino, M., Balana, M.E., Aguirre, G.J., Lupu, R., Elizalde, P.V., Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells (2002) Int J Cancer, 100, pp. 642-653
• Jacobsen, B.M., Richer, J.K., Sartorius, C.A., Horwitz, K.B., Expression profiling of human breast cancers and gene regulation by progesterone receptors (2003) J Mammary Gland Biol Neoplasia, 8, pp. 257-268
• Jacobsen, B.M., Schittone, S.A., Richer, J.K., Horwitz, K.B., Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology (2005) Mol Endocrinol, 19, pp. 574-587
• Lange, C.A., Shen, T., Horwitz, K.B., Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome (2000) Proc Natl Acad Sci USA, 97, pp. 1032-1037
• Skildum, A., Faivre, E., Lange, C.A., Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases (2005) Mol Endocrinol, 19, pp. 327-339
• Wu, J., Brandt, S., Hyder, S.M., Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells (2005) Mol Endocrinol, 19, pp. 312-326
• Tung, L., Mohamed, M.K., Hoeffler, J.P., Takimoto, G.S., Horwitz, K.B., Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors (1993) Mol Endocrinol, 7, pp. 1256-1265
• Viegas, L.R., Vicent, G.P., Baranao, J.L., Beato, M., Pecci, A., Steroid hormones induce bcl-X gene expression through direct activation of distal promoter P4 (2004) J Biol Chem, 279, pp. 9831-9839
• Owen, G.I., Richer, J.K., Tung, L., Takimoto, G., Horwitz, K.B., Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300 (1998) J Biol Chem, 273, pp. 10696-10701
• Vincent, A.J., Zhang, J., Ostor, A., Rogers, P.A., Affandi, B., Kovacs, G., Salamonsen, L.A., Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: A role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding? (2002) Hum Reprod, 17, pp. 1189-1198
• Marbaix, E., Donnez, J., Courtoy, P.J., Eeckhout, Y., Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants (1992) Proc Natl Acad Sci USA, 89, pp. 11789-11793
• Park, D.W., Ryu, H.S., Choi, D.S., Park, Y.H., Chang, K.H., Min, C.K., Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro (2001) Gynecol Oncol, 82, pp. 442-449
• Aguirre Ghiso, J.A., Farias, E.F., Alonso, D.F., Bal de Kier, J.E., Secretion of urokinase and metalloproteinase-9 induced by staurosporine is dependent on a tyrosine kinase pathway in mammary tumor cells (1998) Int J Cancer, 76, pp. 362-367
• Welch, D.R., Technical considerations for studying cancer metastasis in vivo (1997) Clin Exp Metastasis, 15, pp. 272-306
• Chambers, A.F., Groom, A.C., MacDonald, I.C., Dissemination and growth of cancer cells in metastatic sites (2002) Nat Rev Cancer, 2, pp. 563-572
• Luzzi, K.J., MacDonald, I.C., Schmidt, E.E., Kerkvliet, N., Morris, V.L., Chambers, A.F., Groom, A.C., Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases (1998) Am J Pathol, 153, pp. 865-873
• Cameron, M.D., Schmidt, E.E., Kerkvliet, N., Nadkarni, K.V., Morris, V.L., Groom, A.C., Chambers, A.F., MacDonald, I.C., Temporal progression of metastasis in lung: Cell survival, dormancy, and location dependence of metastatic inefficiency (2000) Cancer Res, 60, pp. 2541-2546
• Molinolo, A.A., Lanari, C., Charreau, E.H., Sanjuan, N., Pasqualini, C.D., Mouse mammary tumors induced by medroxyprogesterone acetate: Immunohistochemistry and hormonal receptors (1987) J Natl Cancer Inst, 79, pp. 1341-1350
• Lange, C.A., Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: Who will have the last word? (2004) Mol Endocrinol, 18, pp. 269-278
• Lin, V.C., Jin, R., Tan, P.H., Aw, S.E., Woon, C.T., Bay, B.H., Progesterone induces cellular differentiation in MDA-MB-231 breast cancer cells transfected with progesterone receptor complementary DNA (2003) Am J Pathol, 162, pp. 1781-1787
• Bagowski, C.P., Myers, J.W., Ferrell Jr, J.E., The classical progesterone receptor associates with p42 MAPK and is involved in phosphatidylinositol 3-kinase signaling in Xenopus oocytes (2001) J Biol Chem, 276, pp. 37708-37714
• Grande, M.A., van dK, I., de Jong, L., van Driel, R., Nuclear distribution of transcription factors in relation to sites of transcription and RNA polymerase II (1997) J Cell Sci, 110 (PART 15), pp. 1781-1791
• Elbi, C., Misteli, T., Hager, G.L., Recruitment of dioxin receptor to active transcription sites (2002) Mol Biol Cell, 13, pp. 2001-2015
• Bowden, R.T., Hissom, J.R., Moore, M.R., Growth stimulation of T47D human breast cancer cells by the antiprogestin RU486 (1989) Endocrinology, 124, pp. 2642-2644
• Zhang, Y., Bai, W., Allgood, V.E., Weigel, N.L., Multiple signaling pathways activate the chicken progesterone receptor (1994) Mol Endocrinol, 8, pp. 577-584
• Duffy, M.J., O'Grady, P., Devaney, D., O'Siorain, L., Fennelly, J.J., Lijnen, H.J., Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report (1988) Cancer, 62, pp. 531-533
• Lin, V.C., Eng, A.S., Hen, N.E., Ng, E.H., Chowdhury, S.H., Effect of progesterone on the invasive properties and tumor growth of progesterone receptor-transfected breast cancer cells MDA-MB-231 (2001) Clin Cancer Res, 7, pp. 2880-2886
• Leo, J.C., Wang, S.M., Guo, C.H., Aw, S.E., Zhao, Y., Li, J.M., Hui, K.M., Lin, V.C., Gene regulation profile reveals consistent anticancer properties of progesterone in hormone-independent breast cancer cells transfected with progesterone receptor (2005) Int J Cancer, 117, pp. 561-568
• Sumida, T., Itahana, Y., Hamakawa, H., Desprez, P.Y., Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins (2004) Cancer Res, 64, pp. 7886-7892
• Todaro, L.B., Ladeda, V., Bal de Kier, J.E., Farias, E.F., Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma (2003) Oncol Rep, 10, pp. 725-732
• Saegusa, M., Okayasu, I., Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis (1998) Cancer, 83, pp. 111-121
• Camaggi, C.M., Strocchi, E., Canova, N., Costanti, B., Pannuti, F., Medroxyprogesterone acetate (MAP) and tamoxifen (TMX) plasma levels after simultaneous treatment with 'low' TMX and 'high' MAP doses (1985) Cancer Chemother Pharmacol, 14, pp. 229-231
• Bergkvist, L., Adami, H.O., Persson, I., Hoover, R., Schairer, C., The risk of breast cancer after estrogen and estrogen-progestin replacement (1989) N Engl J Med, 321, pp. 293-297
• Elizalde, P.V., Lanari, C., Molinolo, A.A., Guerra, F.K., Balana, M.E., Simian, M., Iribarren, A.M., Charreau, E.H., Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas (1998) J Steroid Biochem Mol Biol, 67, pp. 305-317
• Urtreger AJ, Grossoni VC, Falbo KB, Kazanietz MG, Bal de Kier Joffe ED 2005 Atypical protein kinase C-zeta modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells. Mol Carcinog 42:29-

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------